Oncology Hematologic / Blood Related Cancers Lymphoma Non-Hodgkins Newly Diagnosed Follicular
Categories
Protocols
SWOG-S2308 Phase III OPEN TO ACCRUAL
Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma